| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |